Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Functional characterization of genetic variations in the MDR3 promoter.

Jang GH, Kim TH, Choe Y, Ham A, Choi JH.

Biochem Biophys Res Commun. 2013 Jan 25;430(4):1312-8. doi: 10.1016/j.bbrc.2012.12.041. Epub 2012 Dec 19.

PMID:
23261441
2.

Identification and functional characterization of novel MATE1 genetic variations in Koreans.

Kim TH, Kim KH, Park HJ, Kim S, Choi JH.

Biochem Biophys Res Commun. 2013 May 3;434(2):334-40. doi: 10.1016/j.bbrc.2013.03.072. Epub 2013 Apr 1.

PMID:
23558289
3.

Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).

Lang T, Haberl M, Jung D, Drescher A, Schlagenhaufer R, Keil A, Mornhinweg E, Stieger B, Kullak-Ublick GA, Kerb R.

Drug Metab Dispos. 2006 Sep;34(9):1582-99. Epub 2006 Jun 8.

4.

Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1.

Ha Choi J, Wah Yee S, Kim MJ, Nguyen L, Ho Lee J, Kang JO, Hesselson S, Castro RA, Stryke D, Johns SJ, Kwok PY, Ferrin TE, Goo Lee M, Black BL, Ahituv N, Giacomini KM.

Pharmacogenet Genomics. 2009 Oct;19(10):770-80. doi: 10.1097/FPC.0b013e328330eeca.

5.

Interindividual transcriptional regulation of the human biglycan gene involves three common molecular haplotypes.

Schmitz B, Salomon A, Rötrige A, Ritter M, Ringelstein EB, Fischer JW, Paul M, Brand E, Brand SM.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):871-80. doi: 10.1161/ATVBAHA.112.301073. Epub 2013 Feb 7.

6.

Identification and Functional Characterization of Novel Genetic Variations in the OCTN1 Promoter.

Park HJ, Choi JH.

Korean J Physiol Pharmacol. 2014 Apr;18(2):169-75. doi: 10.4196/kjpp.2014.18.2.169. Epub 2014 Apr 3.

8.

Polymorphic NF-Y dependent regulation of human nicotine C-oxidase (CYP2A6).

von Richter O, Pitarque M, Rodríguez-Antona C, Testa A, Mantovani R, Oscarson M, Ingelman-Sundberg M.

Pharmacogenetics. 2004 Jun;14(6):369-79.

PMID:
15247629
9.

BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis.

Pauli-Magnus C, Kerb R, Fattinger K, Lang T, Anwald B, Kullak-Ublick GA, Beuers U, Meier PJ.

Hepatology. 2004 Mar;39(3):779-91.

PMID:
14999697
10.

Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.

Zhou D, Masri S, Ye JJ, Chen S.

Gene. 2005 Nov 21;361:89-100. Epub 2005 Sep 21.

PMID:
16181749
11.

Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy.

Pauli-Magnus C, Lang T, Meier Y, Zodan-Marin T, Jung D, Breymann C, Zimmermann R, Kenngott S, Beuers U, Reichel C, Kerb R, Penger A, Meier PJ, Kullak-Ublick GA.

Pharmacogenetics. 2004 Feb;14(2):91-102.

PMID:
15077010
15.
16.
17.

p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.

Faniello MC, Di Sanzo M, Quaresima B, Baudi F, Di Caro V, Cuda G, Morrone G, Del Sal G, Spinelli G, Venuta S, Costanzo F.

Int J Biochem Cell Biol. 2008;40(10):2110-9. doi: 10.1016/j.biocel.2008.02.010. Epub 2008 Feb 17.

PMID:
18372207
18.

The transcription factor CCAAT-binding factor CBF/NF-Y regulates the proximal promoter activity in the human alpha 1(XI) collagen gene (COL11A1).

Matsuo N, Yu-Hua W, Sumiyoshi H, Sakata-Takatani K, Nagato H, Sakai K, Sakurai M, Yoshioka H.

J Biol Chem. 2003 Aug 29;278(35):32763-70. Epub 2003 Jun 12.

20.

Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene.

Takane H, Kobayashi D, Hirota T, Kigawa J, Terakawa N, Otsubo K, Ieiri I.

J Pharmacol Exp Ther. 2004 Dec;311(3):1179-87. Epub 2004 Jul 27.

Items per page

Supplemental Content

Write to the Help Desk